Steven Jacobson
National Institute of Neurological Disorders and Stroke (NINDS)
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Registry trials as an overall official
6
all conditions, ClinicalTrials.gov
NIH grants tied to them
7
NIH RePORTER
Trial papers
89
PubMed author-name match
Trials
Studies that name Steven Jacobson as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-11 19:34 UTC. Open this list on ClinicalTrials.gov
- Ph1/Ph2NCT04799288 · Teriflunomide in HTLV-1 Associated Myelopathy/Tropical Spastic ParaparesisNational Institute of Neurological Disorders and Stroke (NINDS) · recruiting · HAM/TSP · principal investigator
- Early Ph1NCT01867320 · Raltegravir for HAM/TSPNational Institute of Neurological Disorders and Stroke (NINDS) · completed · HTLV-I Infection · principal investigator
- Ph1NCT00432900 · Brain Peripheral Benzodiazepine Receptors in Patients With Multiple SclerosisNational Institute of Neurological Disorders and Stroke (NINDS) · completed · Multiple Sclerosis · principal investigator
- N/ANCT00325988 · Biomarkers in Multiple SclerosisNational Institute of Neurological Disorders and Stroke (NINDS) · completed · Multiple Sclerosis · principal investigator
- Ph1NCT00076843 · Hu Mik-Beta-1 to Treat HTLV-1-Associated Myelopathy/Tropical Spastic ParaparesisNational Institute of Neurological Disorders and Stroke (NINDS) · completed · HTLV-1 · principal investigator
- N/ANCT00001778 · Evaluation of Patients With HAM/TSPNational Institute of Neurological Disorders and Stroke (NINDS) · recruiting · HTLV-I Infection, Tropical Spastic Paraparesis · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-11 19:34 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
- Immunologic Mechanisms In Experimental Autoimmune Diseases Of The Nervous SystemZIANS002204 · NINDS · NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE · fiscal years 2009 to 2025 · $362,402 awarded in 2025Same name and institution; not confirmed by an ID
- Involvement Of Human Viruses Associated With Chronic Neurologic DiseaseZIANS002817 · NINDS · NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE · fiscal years 2009 to 2025 · $715,738 awarded in 2025Same name and institution; not confirmed by an ID
- Single Cell RNA Sequencing of Blood and CSF of Patients with NeuroAIDSZIANS009448 · NINDS · NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE · fiscal years 2022 to 2025 · $300,000 awarded in 2025Same name and institution; not confirmed by an ID
- Translational studies of human viruses and chronic neurologic diseaseZIANS003040 · NINDS · NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE · fiscal years 2009 to 2025 · $394,129 awarded in 2025Same name and institution; not confirmed by an ID
- Examination Of Natural History And Therapy Of Multiple Sclerosis Using MRIZIANS002853 · NINDS · NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE · fiscal years 2009 · $1,766,999 awarded in 2009Same name and institution; not confirmed by an ID
- Involvement Of Human Viruses Associated With Chronic Neurologic DiseaseZ01NS002817 · NINDS · NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE · fiscal years 1992 to 2008 · $1,983,212 awarded in 2008Same name and institution; not confirmed by an ID
- Translational studies of human viruses and chronic neurologic disesaeZ01NS003040 · NINDS · NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE · fiscal years 2007 to 2008 · $849,948 awarded in 2008Same name and institution; not confirmed by an ID
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-11 19:34 UTC. The ranking covers the 200 most relevant of 89 PubMed records, and a shared surname and initials can bring in a namesake. All 89 on PubMed
- Treatment of leber congenital amaurosis due to RPE65 mutations by ocular subretinal injection of adeno-associated virus gene vector: short-term results of a phase I trial.Hum Gene Ther · 2008817 citationsRCR 20.3
- Human gene therapy for RPE65 isomerase deficiency activates the retinoid cycle of vision but with slow rod kinetics.Proc Natl Acad Sci U S A · 2008583 citationsRCR 14.9
- Gene therapy for leber congenital amaurosis caused by RPE65 mutations: safety and efficacy in 15 children and adults followed up to 3 years.Arch Ophthalmol · 2012533 citationsRCR 16.9
- Effect of membrane permeability on survival of hemodialysis patients.J Am Soc Nephrol · 2009312 citationsRCR 11.6
- Improvement and decline in vision with gene therapy in childhood blindness.N Engl J Med · 2015309 citationsRCR 10.2
- Pembrolizumab Treatment for Progressive Multifocal Leukoencephalopathy.N Engl J Med · 2019289 citationsRCR 11.9
- Human RPE65 gene therapy for Leber congenital amaurosis: persistence of early visual improvements and safety at 1 year.Hum Gene Ther · 2009263 citationsRCR 6.3
- Linaclotide inhibits colonic nociceptors and relieves abdominal pain via guanylate cyclase-C and extracellular cyclic guanosine 3',5'-monophosphate.Gastroenterology · 2013239 citationsRCR 8.6
- Prospective multicentre study of pregnancy outcome after lithium exposure during first trimester.Lancet · 1992204 citationsRCR 9.2
- Safety and efficacy of intravenous glyburide on brain swelling after large hemispheric infarction (GAMES-RP): a randomised, double-blind, placebo-controlled phase 2 trial.Lancet Neurol · 2016202 citationsRCR 8.1